Israel Englander’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-2,168
Closed -$301K 6746
2023
Q2
$301K Sell
2,168
-27,918
-93% -$3.58M ﹤0.01% 4883
2023
Q1
$2.74M Buy
30,086
+20,064
+200% +$2.72M ﹤0.01% 3133
2022
Q4
$1.37M Sell
10,022
-45,747
-82% -$15.5M ﹤0.01% 3869
2022
Q3
$48.4M Buy
55,769
+25,581
+85% +$16M 0.03% 700
2022
Q2
$13.2M Sell
30,188
-32,453
-52% -$16.9M 0.01% 1718
2022
Q1
$39.8M Buy
62,641
+23,544
+60% +$14.8M 0.02% 836
2021
Q4
$34.8M Sell
39,097
-12,626
-24% -$13.3M 0.02% 972
2021
Q3
$65.6M Buy
51,723
+35,077
+211% +$42.5M 0.04% 502
2021
Q2
$20.1M Buy
16,646
+10,575
+174% +$14.3M 0.01% 1190
2021
Q1
$8.04M Sell
6,071
-1,366
-18% -$1.93M 0.01% 2031
2020
Q4
$9.97M Sell
7,437
-26,663
-78% -$30.5M 0.01% 1736
2020
Q3
$35.5K Buy
+34,100
New +$35.6M 0.04% 474

Other funds holding CANO

Israel Englander's CANO Position: Q3 2023 in Review

Israel Englander sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 2,168 shares — an estimated $301K sold.

Israel Englander first reported a position in CANO in Q3 2020 and held it in 12 quarters. The position peaked at $65.6M in Q3 2021. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

  • Israel Englander reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
  • Israel Englander sold 2,168 Cano Health, Inc. shares in Q3 2023, an estimated $301K.
  • Israel Englander first reported a position in Cano Health, Inc. in Q3 2020 and held it in 12 quarters.
  • Israel Englander's Cano Health, Inc. position peaked at $65.6M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.